Status:
ACTIVE_NOT_RECRUITING
Asymmetrical HFNCO vs Standard HFNCO Post Cardiac Surgery Patients
Lead Sponsor:
National and Kapodistrian University of Athens
Conditions:
Hypoxemic Respiratory Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
High-flow oxygen therapy has been applied after extubation in cardiac surgery patients with a well-known successful efficacy. The current authors plan to conduct a prospective, randomized, controlled ...
Detailed Description
Over the last decade, High Flow Nasal Cannula Oxygenation,(HFNCO) has proven successfully its capability in the management of hypoxemic respiratory failure patients post cardiac surgery. Efficient oxy...
Eligibility Criteria
Inclusion
- Cardiac ICU adult patients
- \>18 years
- After elective or urgent cardiac surgery
- Successful Spontaneous Breathing Trial (SBT) with T-piece and FiO2=60%.
- pO2/ FiO2 \<150
- Hemodynamically stable (160\>SAP\>90mmHg)
Exclusion
- Obstructive Sleep Apnea Syndrome supported by CPAP mask on ventilator
- COPD, officially diagnosed, respiratory failure - on exacerbation with serum blood pH \<7,35.
- Patients with tracheostomy,
- DNR status,
- Glasgow Coma Scale score \< 13,
- Insufficient knowledge of the Greek Language
- Visual or hearing impairment.
Key Trial Info
Start Date :
May 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2026
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT06521489
Start Date
May 1 2024
End Date
February 28 2026
Last Update
October 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Evangelismos General Hospital of Athens
Athens, Attica, Greece, 10676